GILSTON GROUP (02011) announced its annual performance, with a net profit attributable to shareholders of HK$23.814 million, representing a decrease of 26.3% compared to the previous year.
Tencent Group (02011) released its annual performance for the year ending December 31, 2025. The group achieved revenue of HK$383 million, a year-on-year increase of 14.9%; net profit attributable to equity shareholders was HK$238.14 million, a year-on-year decrease of 26.3%; earnings per share were 4.1 HK cents.
GILSTON Group (02011) announced its annual performance for the year ending December 31, 2025. The group achieved revenue of HK$383 million, an increase of 14.9% compared to the previous year; net profit attributable to equity shareholders was HK$23.814 million, a decrease of 26.3%; earnings per share were 4.1 Hong Kong cents.
The announcement stated that the increase in revenue was mainly due to the full recognition of income from operating Jialong Automobile City during the year, while in 2024, income was derived from providing management services and sharing revenue through management agreements.
Related Articles

PALINDA GROUP (08179) announced its annual performance, with a net loss of 98.03 million Hong Kong dollars attributable to shareholders, a turnaround from a profit in the same period last year.

Guangzhou Automobile Group (02238) plans to sell a 12% equity stake in Xinjiang Kunlun Blue Diamond Mining Development Co., Ltd. for 1.92 billion yuan.

TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.
PALINDA GROUP (08179) announced its annual performance, with a net loss of 98.03 million Hong Kong dollars attributable to shareholders, a turnaround from a profit in the same period last year.

Guangzhou Automobile Group (02238) plans to sell a 12% equity stake in Xinjiang Kunlun Blue Diamond Mining Development Co., Ltd. for 1.92 billion yuan.

TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


